REFERENCES

• KesslerRC.McGonagleKA.ZhaoS.et al.Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey.Arch Gen Psychiatry.1994518198279933
   PubMed Web of Science ®Google Scholar
• BurkeKC.BurkeJD.JrRaeDS.et al.Comparing age at onset of major depression and other psychiatric disorders by birth cohorts in five US community populations.Arch Gen Psychiatry.1991487897951929768
   PubMed Web of Science ®Google Scholar
• RubinowDR.SchmidtPJ.RocaCA.Estrogen-serotonin interactions: implications for affective regulation.Biol Psychiatry.1998448398509807639
   PubMed Web of Science ®Google Scholar
• BlochM.SchmidtPJ.DanaceauM.MurphyJ.NiemanL.RubinowDR.Effects of gonadal steroids in women with a history of postpartum depression.Am J Psychiatry.200015792493010831472
   PubMed Web of Science ®Google Scholar
• EndicottJ.AmsterdamJ.ErikssonE.et al.Is premenstrual dysphoric disorder a distinct clinical entity?J Womens Health Gend Based Med.1999866367910839653
   PubMedGoogle Scholar
• American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association;1994
   Google Scholar
• SinghBB.BermanBM.SimpsonRL.AnnechildA.Incidence of premenstrual syndrome and remedy usage: a national probability sample study.Altern Ther Health Med.1998475799581324
   PubMed Web of Science ®Google Scholar
• CampbellEM.PeterkinD.O'GradyK.Sanson-FisherR.Premenstrual symptoms in general practice patients: prevalence and treatment.J Reprod Med.1997426376469350019
   PubMed Web of Science ®Google Scholar
• AngstJ.SellaroR.StolarM.MerikangasKR.EndicottJ.The epidemiology of perimenstrual psychological symptoms.Acta Psychiatr Scand.200110411011611473504
   PubMed Web of Science ®Google Scholar
• RamcharanS.LoveEJ.FickGH.GoldfienA.The epidemiology of premenstrual symptoms in a population-based sample of 2650 urban women: attributable risk and risk factors.J Clin Epidemiol.1992453773921569434
   PubMed Web of Science ®Google Scholar
• DeusterPA.AderaT.South-PaulJ.Biological, social, and behavioral factors associated with premenstrual syndrome.Arch Fam Med.1999812212810101982
   PubMedGoogle Scholar
• YonkersKA.The association between premenstrual dysphoric disorder and other mood disorders.J Clin Psychiatry.199758(suppl 15)19259427873
   PubMed Web of Science ®Google Scholar
• HalbreichU.BergeronR.FreemanE.StoutA.CohenL.Intermittent luteal phase dosing of sertraline effective in PMDD.Int J Neuropsychopharmacol .20003(suppl 1)S248
   Google Scholar
• EndicottJ.HalbreichU.Clinical significance of premenstrual dysphoric changes.J Clin Psychiatry.1988494864893198580
   PubMed Web of Science ®Google Scholar
• ErikssonE.Serotonin reuptake inhibitors for the treatment of premenstrual dysphoria.Int Clin Psychopharmacol.199914(suppl 2)S27S3310471170
   PubMed Web of Science ®Google Scholar
• ErikssonE.AnderschB.HoHP.et al.Premenstrual dysphoria: an illustrative example of how serotonin modulates sex-steroid-related behavior.CNS Spectrums.20016141149
   Google Scholar
• KendlerKS.KarkowskiLM.CoreyLA.NealeMC.Longitudinal population-based twin study of retrospectively reported premenstrual symptoms and lifetime major depression.Am J Psychiatry.1998155123412409734548
   PubMed Web of Science ®Google Scholar
• FreemanEW.RickelsK.SondheimerSJ.et al.Differential response to antidepressants in women with premenstrual syndrome: a randomized controlled trial.Arch Gen Psychiatry.19995693293910530636
   PubMed Web of Science ®Google Scholar
• FreemanEW.SondheimerSJ.PolanskyM.Garcia-EspagnaB.Predictors of response to sertraline treatment of severe premenstrual syndromes.J Clin Psychiatry.20006157958410982201
   PubMedGoogle Scholar
• BrzezinskiAA.WurtmanJJ.WurtmanRJ.GleasonR.GreenfieldJ.NaderT. d-Fenfluramine suppresses the increased calorie and carbohydrate intakes and improves the mood of women with premenstrual depression.Obstet Gynecol.1990762963002371034
   PubMed Web of Science ®Google Scholar
• RickelsK.FreemanE.SondheimerS.Buspirone in treatment of premenstrual syndrome.Lancet.198947772564578
   PubMedGoogle Scholar
• RubinowDR.Roy-ByrneP.HobanMC.GoldPW.PostRM.Prospective assessment of menstrually related mood disorders.Am J Psychiatry.19841416846866538762
   PubMed Web of Science ®Google Scholar
• HartWG.ColemanGJ.RussellJW.Assessment of premenstrual symptomatology: a re-evaluation of the predictive validity of self-report.J Psychosom Res.1987311851903585820
   PubMed Web of Science ®Google Scholar
• EnsomMH.ChongE.CarterD.Premenstrual symptoms in women with premenstrual asthma.Pharmacotherapy.19991937438210212006
   PubMed Web of Science ®Google Scholar
• ChandlerMH.SchuldheiszS.PhillipsBA.MuseKN.Premenstrual asthma: the effect of estrogen on symptoms, pulmonary function, and beta 2-receptors.Pharmacotherapy.1997172242349085312
   PubMed Web of Science ®Google Scholar
• SilbersteinSD.Hormone-related headache.Med Clin North Am.2001851017103511480256
   PubMed Web of Science ®Google Scholar
• RosciszewskaD.Analysis of seizure dispersion during menstrual cycle in women with epilepsy.Monogr Neural Sci.198052802847198716
   PubMedGoogle Scholar
• McLeodDR.FosterGV.Hoehn-SaricR.SvikisDS.HipsleyPA.Family history of alcoholism in women with generalized anxiety disorder who have premenstrual syndrome: patient reports of premenstrual alcohol consumption and symptoms of anxiety.Alcohol Clin Exp Res.1994186646707943673
   PubMed Web of Science ®Google Scholar
• MarksJL.HairCS.KlockSC.GinsburgBE.PomerleauCS.Effects of menstrual phase on intake of nicotine, caffeine, and alcohol and nonprescribed drugs in women with late luteal phase dysphoric disorder.J Subst Abuse.199462352437804022
   PubMedGoogle Scholar
• ChoiSH.KangSB.JoeSH.Changes in premenstrual symptoms in women with schizophrenia: a prospective study.Psychosom Med.20016382282911573031
   PubMed Web of Science ®Google Scholar
• RojanskyN.HalbreichU.ZanderK.BarkaiA.GoldsteinS.Imipramine receptor binding and serotonin uptake in platelets of women with premenstrual changes.Gynecol Obstet Invest.1991311461521649111
   PubMed Web of Science ®Google Scholar
• Jr AshbyCR.CarrLA.CookCL.SteptoeMM.FranksDD.Alteration of 5-HT uptake by plasma fractions in the premenstrual syndrome.J Neural Transm (Gen Sect).19907941502297397
   PubMed Web of Science ®Google Scholar
• TaylorDL.MatthewRJ.HoBT.WienmanML.Serotonin levels and platelet uptake during premenstrual tension.Neuropsychobiology.19841216186542630
   PubMed Web of Science ®Google Scholar
• RapkinAJ.EdelmuthE.ChangLC.ReadingAE.McGuireMT.SuTP.Whole-blood serotonin in premenstrual syndrome.Obstet Gynecol.1987705335373627623
   PubMed Web of Science ®Google Scholar
• RapkinAJ.ChangLC.ReadingAE.Tryptophan loading test in premenstrual syndrome.J Obstet Gynecol.198910140144
   Google Scholar
• MenkesDB.CoatesDC.FawcettJP.Acute tryptophan depletion aggravates premenstrual-syndrome.J Affect Disord.19943237447798465
   PubMed Web of Science ®Google Scholar
• SteinbergS.AnnableL.YoungSN.LiyanageN.A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria.Biol Psychiatry.19994531332010023508
   PubMed Web of Science ®Google Scholar
• FitzGeraldM.MaloneKM.ShuhuaL.et al.Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder.Am J Psychiatry.19971545565589090347
   PubMed Web of Science ®Google Scholar
• SuTP.SchmidtPJ.DanaceauM.MurphyDL.RubinowDR.J Clin Endocrinol Metab.199782122012289100599
   PubMed Web of Science ®Google Scholar
• DimmockPW.WyattKM.JonesPW.Shaughn O'Brien PM.Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review.Lancet.20003561131113611030291
   PubMed Web of Science ®Google Scholar
• SteinerM.SteinbergS.StewartD.et al.Fluoxetine in the treatment of premenstrual dysphoria.N Engl J Med.1995332152915347739706
   PubMed Web of Science ®Google Scholar
• WoodSH.MortolaJF.ChanYF.MoossazadehF.YenSS.Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study.Obstet Gynecol.1992803393441495689
   PubMed Web of Science ®Google Scholar
• MenkesDB.TaghaviE.MasonPA.Fluoxetine treatment of severe premenstrual syndrome.BMJ.19923053463471392887
   PubMed Web of Science ®Google Scholar
• OzerenS.CorakciA.YucesoyI.MercanR.ErhanG.Fluoxetine in the treatment of premenstruaI syndrome.Eur J Obstet Gynecol Reprod Biol.1997731671709228499
   PubMed Web of Science ®Google Scholar
• PearlsteinTB.StoneAB.LundSA.Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder.J Clin Psychopharmacol.1997172612669241004
   PubMed Web of Science ®Google Scholar
• SuTP.SchmidtPJ.DanaceauMA.et al.Fluoxetine in the treatment of premenstrual dysphoria.Neuropsychopharmacology.1997163463569109106
   PubMed Web of Science ®Google Scholar
• YonkersKA.HalbreichU.FreemanE.et al.Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial.JAMA.19972789839889307345
   PubMed Web of Science ®Google Scholar
• YoungSA.HurtPH.BenedekDM.HowardRS.Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomized, double-blind, placebo-controlled crossover trial.J Clin Psychiatry.19985976809501889
   PubMed Web of Science ®Google Scholar
• JermainDM.PreeceCK.SykesRL.KuehlTJ.SulakPJ.Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study.Arch Fam Med.1999832833210418540
   PubMedGoogle Scholar
• HalbreichU.SmollerJW.Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome.J Clin Psychiatry.1997583994029378691
   PubMed Web of Science ®Google Scholar
• ErikssonE.HedbergA.AnderschB.SundbladC.The SRI paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome: a placebo-controlled trial.Neuropsychopharmacology.1995121671767779245
   PubMed Web of Science ®Google Scholar
• WikanderI.SundbladC.AnderschB.et al.Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle?J Clin Psychopharmacol.1998183903989790157
   PubMed Web of Science ®Google Scholar
• FreemanEW.RickelsK.YonkersKA.KunzNR.McPhersonM.UptonGV.Venlafaxine in the treatment of premenstrual dysphoric disorder.Obstet Gynecol.20019873774411704162
   PubMed Web of Science ®Google Scholar
• SundbladC.ModighK.AnderschB.et al.Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial.Acta Psychiatr Scand.19928539471546547
   PubMed Web of Science ®Google Scholar
• SundbladC.HedbergM.ErikssonE.Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial.Neuropsychopharmacology.199391331458216696
   PubMed Web of Science ®Google Scholar
• FreemanEW.RickelsK.SondheimerSJ.DenisA.PfeiferS.WeilS.Nefazodone in the treatment of premenstrual syndrome: a preliminary study.J Clin Psychopharmacol.1994141801868027414
   PubMed Web of Science ®Google Scholar
• FreemanEW.RickelsK.SondheimerSJ.Fluvoxamine for premenstrual dysphoric disorder: a pilot study.J Clin Psychiatry.199657(suppl 8)56598698682
   PubMed Web of Science ®Google Scholar
• AltshulerLL.CohenLS.MolineML.KahnDA.CarpenterD.DochertyJP.The Expert Consensus Guideline Series: treatment of depression in women. 2001.Postgrad Med.2001(March)111611500997
   PubMedGoogle Scholar
• KennedySH.EisfeldBS.DickensSE.BacciochiJR.BagbyRM.Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline and venlafaxine.J Clin Psychiatry.20006127628110830148
   PubMed Web of Science ®Google Scholar
• SundbladC.HedbergMA.ErikssonE.Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial.Neuropsychopharmacology.199391331458216696
   PubMed Web of Science ®Google Scholar
• FreemanEW.RickelsK.ArredondoF.KaoLC.PollackSE.SondheimerSJ.Full or half-cycle treatment of severe premenstrual syndrome with a serotonergic antidepressant.J Clin Psychopharmacology.19991938
   PubMed Web of Science ®Google Scholar
• JudgeR.BrownE.MinerC.DillonJ.Intermittent fluoxetine dosing in premenstrual dysphoric disorder. Abstract 0161.Arch Womens Ment Health.20013(suppl 2)1116
   Google Scholar
• YonkersKA.BarnettLK.CarmodyT.RushAJ.Serial discontinuation of SSRI treatment for PMDD.Biol Psychiatry.199843151335
   Web of Science ®Google Scholar
• PearlsteinTB.StoneAB.Long-term fluoxetine treatment of late luteal phase dysphoric disorder.J Clin Psychiatry.1994553323358071300
   PubMed Web of Science ®Google Scholar
• ElksML.Open trial of fluoxetine therapy for premenstrual syndrome.South Med J.1993865035078488394
   PubMed Web of Science ®Google Scholar
• FreemanEW.RickelsK.SondheimerSJ.Course of premenstrual syndrome symptom severity after treatment.Am J Psychiatry.19921495315331554040
   PubMed Web of Science ®Google Scholar
• SchmidtPJ.NiemanLK.DanaceauMA.et al.Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome.N Engl J Med.19983382092169435325
   PubMed Web of Science ®Google Scholar
• BrownCS.LingFW.AndersenRN.et al.Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial.Obstet Gynecol.1994847797867936512
   PubMed Web of Science ®Google Scholar
• FreemanEW.SondheimerSJ.RickelsK.Gonadotropin-releasing hormone agonist in treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study.Psychopharmacol Bull.1997333033099230648
   PubMed Web of Science ®Google Scholar
• HammarbackS.BäckströmT.Induced anovulation as treatment of premenstrual tension syndrome: a double-blind cross-over study with GnRH-agonist versus placebo.Acta Obstet Gynecol Scand.1988671591663140572
   PubMed Web of Science ®Google Scholar
• HussainSY.MassilJH.MattaWH.et al.Buserelin in premenstrual syndrome.Gynecol Endocrinol.1992657641580169
   PubMed Web of Science ®Google Scholar
• LeatherAT.StuddJWW.WatsonNR.HollandEFN.The treatment of severe premenstrual syndrome with goserelin with and without “addback” estrogen therapy: a placebo-controlled study.Gynecol Endocrinol.199913485510368798
   PubMed Web of Science ®Google Scholar
• MortolaJF.GirtonL.FischerU.Successful treatment of severe premenstrual syndrome by combined used of gonadotropin-releasing hormone agonist and estrogen/progestin.J Clin Endocrinol Metab.199171252257
   Web of Science ®Google Scholar
• MezrowG.ShoupeD.SpicerD.LoboR.LeungB.PikeM.Depot leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome.Fertil Steril.1994629329377926137
   PubMed Web of Science ®Google Scholar
• Di CarloC.PalombaS.TommaselliGA.GuidaM.Di Spiezio SardoA.NappiC.Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome.Fertil Steril.20017538038411172843
   PubMed Web of Science ®Google Scholar
• GrahamCA.SherwinBB.A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive.J Psychosom Res.1992362572661564678
   PubMed Web of Science ®Google Scholar
• BäckströmT.Hansson-MalmströmY.LindheBA.Cavalli-BjörkmanB.NordenströmS.Oral contraceptives in premenstrual syndrome: a randomized comparison of triphasic and monophasic preparations.Contraception.1992462532681451521
   PubMed Web of Science ®Google Scholar
• FreemanEW.KrollR.RapkinA.et al.Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder.J Womens Health Gend Based Med.20011056156911559453
   PubMedGoogle Scholar
• WalkerA.BancroftJ.Relationship between premenstrual symptoms and oral contraceptive use: a controlled study.Psychosom Med.19905286962305025
   PubMed Web of Science ®Google Scholar
• SveindóttirH.BäckströmT.Prevalence of menstrual cycle symptom cyclicity and premenstrual dysphoric disorder in a random sample of women using and not using oral contraceptives.Acta Obstet Gynecol Scand.20007940541310830769
   PubMed Web of Science ®Google Scholar
• TiemstraJD.PatelK.Hormonal therapy in the management of premenstrual syndrome.J Am Board Earn Pract.199811378381
   Google Scholar
• MagosAL.BrincatM.StuddJWW.Treatment of the premenstrual syndrome by subcutaneous oestradiol implants and cyclical oral norethisterone: placebo-controlled study.BMJ.1986292162916333087550
   PubMed Web of Science ®Google Scholar
• WatsonNR.SavvasM.StuddJWW.GarnettT.BaberRJ.Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone.Lancet.198927307322570971
   PubMed Web of Science ®Google Scholar
• SmithRNJ.StuddJWW.ZambleraD.HollandEFN.A randomised comparison over 8 months of 100 μg and 200 μg twice weekly doses of transdermal oestradiol in the treatment of severe premenstrual syndrome.Br J Obstet Gynaecol.19951024754847632640
   PubMedGoogle Scholar
• MaddocksS.HahnP.MollerF.ReidRL.A double-blind placebo-controlled trial of progesterone vaginal suppositories in the treatment of premenstrual syndrome.Am J Obstet Gynecol.19861545735813513587
   PubMed Web of Science ®Google Scholar
• FreemanE.RickelsK.SondheimerSJ.PolanskyM.Ineffectiveness of progesterone suppository treatment for premenstrual syndrome.JAMA.19902643493532194047
   PubMed Web of Science ®Google Scholar
• FreemanEW.RickelsK.SondheimerSJ.PolanskyM.A double-blind trial of oral progesterone, alprazolam and placebo in treatment of severe premenstrual syndrome.JAMA.199527451577791258
   PubMed Web of Science ®Google Scholar
• BergerCP.PresserB.Alprazolam in the treatment of two subsamples of patients with late luteal phase dysphoric disorder: a double-blind, placebo-controlled crossover study.Obstet Gynecol.1994843793858058235
   PubMed Web of Science ®Google Scholar
• HarrisonWM.EndicottJ.NeeJ.Treatment of premenstrual dysphoria with alprazolam: a controlled study.Arch Gen Psychiatry.1990472702752407209
   PubMed Web of Science ®Google Scholar
• SmithS.RinehartJS.RuddockVE.et al.Treatment of premenstrual syndrome with alprazolam: results of a double-blind, placebo-controlled, randomized crossover clinical trial.Obstet Gynecol.19877037433299178
   PubMed Web of Science ®Google Scholar
• RickelsK.FreemanEW.SondheimerSJ.Buspirone in treatment of premenstrual syndrome.Lancet.198917772564578
   PubMed Web of Science ®Google Scholar
• SchmidtPJ.GroverGN.RubinowDR.Alprazolam in the treatment of premenstrual syndrome: a double-blind, placebo-controlled trial.Arch Gen Psychiatry.1993504674738498881
   PubMed Web of Science ®Google Scholar
• DennersteinL.MorseC.BurrowsG.BrownJ.SmithM.Alprazolam in the treatment of premenstrual syndrome. In: Dennerstein L, Fraser I, eds.Hormones and Behavior. New York NY Elsevier Science Publishing;1986175182
   Google Scholar
• PearlsteinT.SteinerM.Non-antidepressant treatment of premenstrual syndrome.J Clin Psychiatry.200061(suppl 12)222711041381
   PubMed Web of Science ®Google Scholar
• Thys-JacobsS.StarkeyP.BernsteinD.et al.Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms.Am J Obstet Gynecol.19981794444529731851
   PubMed Web of Science ®Google Scholar
• WyattKM.DimmockPW.JonesPW.Shaughn O'BrienPM.Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review.BMJ.19993181375138110334745
   PubMed Web of Science ®Google Scholar
• StevinsonC.ErnstE.Complementary/alternative therapies for premenstrual syndrome: a systematic review of randomized controlled trials.Am J Obstet Gynecol.200118522723511483933
   PubMed Web of Science ®Google Scholar
• den TonkelaarI.te VeldeER.LoomanCW.Menstrual cycle length preceding menopause in relation to age at menopause.Maturitas.1998291151239651900
   PubMed Web of Science ®Google Scholar
• TreloarAE.BoyntonRE.BehnBG.BrownBW.Variation of the human menstrual cycle through reproductive life.Int J Fertil.197012771265419031
   PubMedGoogle Scholar
• TreloarAE.Menstrual cyclicity and the pre-menopause.Maturitas.198132492647334935
   PubMed Web of Science ®Google Scholar
• CooperGS.BairdDD.DardenFR.Measures of menopausal status in relation to demographic, reproductive, and behavioral characteristics in a population-based study of women aged 35-49 years.Am J Epidemiol.20011531159116511415950
   PubMed Web of Science ®Google Scholar
• AvisNE.BrambillaD.McKinlaySM.VassK.A longitudinal analysis of the association between menopause and depression. Results from the Massachusetts Women's Health Study.Ann Epidemiol.199442142208055122
   PubMedGoogle Scholar
• KaufertPA.GilbertP.TateR.The Manitoba Project: a re-examination of the link between menopause and depression.Maturitas.1992141571601565023
   PubMed Web of Science ®Google Scholar
• MatthewsKA.WingRR.KullerLJ.MeilahnEN.KelseySF.Influences of natural menopause on psychological characteristics and symptoms of middle-aged healthy women.J Consult Clin Psychol.1990483453512365898
   PubMedGoogle Scholar
• Nicol-SmithL.Causality, menopause and depression: a critical review of the literature.BMJ.1996313122912328939110
   PubMed Web of Science ®Google Scholar
• BlazerDG.KesslerRC.McGonagleKA.SwartzMS.The prevalence and distribution of major depression in a national community sample: the national comorbidity survey.Am J Psychiatry.19941519799868010383
   PubMed Web of Science ®Google Scholar
• KesslerRC.McGonagleKA.SwartzM.BlazerDG.NelsonCB.Sex and depression in the national comorbidity survey. I: lifetime prevalence, chronicity and recurrence.J Affect Disord.19932985968300981
   PubMed Web of Science ®Google Scholar
• RobertsRE.VernonSW.The center for epidemiologic studies depression scale: its use in a community sample.Am J Psychiatry.198314041466847983
   PubMed Web of Science ®Google Scholar
• KellerMB.LavoriPW.MuellerTl.et al.Time to recovery, chronicity, and levels of psychopathology in major depression: a 5-year prospective followup of 431 subjects.Arch Gen Psychiatry.1992498098161417434
   PubMed Web of Science ®Google Scholar
• AvisNE.StellatoR.CrawfordS.et al.Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups.Soc Sci Med.20015234535611330770
   PubMed Web of Science ®Google Scholar
• DennersteinL.DudleyEC.HopperJL.GuthrieJR.BurgerHG.A prospective population-based study of menopausal symptoms.Obstet Gynecol.20009635135810960625
   PubMed Web of Science ®Google Scholar
• BosworthHB.BastianLA.KuchibhatlaMN.et al.Depressive symptoms, menopausal status, and climacteric symptoms in women at midlife.Psychom Med.200163603608
   PubMed Web of Science ®Google Scholar
• ScaresCN.AlmeidaOP.Depression during the perimenopause.Arch Gen Psychiatry.200158306
   Web of Science ®Google Scholar
• WhooleyMA.GradyD.CauleyJA.Postmenopausal estrogen therapy and depressive symptoms in older women.J Gen Intern Med.20001553554110940144
   PubMed Web of Science ®Google Scholar
• Carranza-LiraS.Valentino-FigueroaML.Estrogen therapy for depression in postmenopausal women.Int J Gynaecol Obstet.199964353810190667
   PubMed Web of Science ®Google Scholar
• ZweifelJE.O'BrienWH.A meta-analysis of the effect of hormone replacement therapy upon depressed mood.Psychoneuroendocrinology.1997221892129203229
   PubMed Web of Science ®Google Scholar
• PalinkasLA.Barrett-ConnorE.Estrogen use and depressive symptoms in postmenopausal women.Obstet Gynecol.19928030361603493
   PubMed Web of Science ®Google Scholar
• DitkoffEC.CraryWG.CristaM.LoboRA.Estrogen improves psychological function in asymptomatic postmenopausal women.Obstet Gynecol.1991789919951658700
   PubMed Web of Science ®Google Scholar
• SaletuB.BrandstatterN.MetkaM.et al.Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with transdermal oestradiol therapy in menopausal depression.Psychopharmacology (Berl).19951223213298657828
   PubMed Web of Science ®Google Scholar
• CoopeJ.Is oestrogen therapy effective in the treatment of menopausal depression?J R Coll Gen Pract.1981311341406268783
   PubMedGoogle Scholar
• StricklerRC.BorthR.CecuttiA.et al.The role of oestrogen replacement in the climacteric syndrome.Psychol Med.19777631639201958
   PubMed Web of Science ®Google Scholar
• ThomsonJ.OswaldI.Effect of oestrogen on the sleep, mood, and anxiety of menopausal women.BMJ.1977213171319338104
   PubMed Web of Science ®Google Scholar
• BurtVK.AltshulerLL.RasgonN.Depressive symptoms in the perimenopause: prevalence, assessment, and guidelines for treatment.Harvard Rev Psychiatry.19986121132
   PubMed Web of Science ®Google Scholar
• CampbellS.WhiteheadM.Oestrogen therapy and the menopausal syndrome.Clin Obstet Gynaecol.197743147322905
   PubMed Web of Science ®Google Scholar
• SchneiderMA.BrothertonPL.HailesJ.The effect of exogenous oestrogens on depression in menopausal women.Arch Gen Psychiatry.19772162163
   Google Scholar
• KlaiberEL.BrovermanDM.VogelW.KobayashiY.Estrogen therapy for severe persistent depressions in women.Arch Gen Psychiatry.197936550554219802
   PubMed Web of Science ®Google Scholar
• FuruhjelmM.KarlgrenE.CarlströmK.The effect of estrogen therapy on somatic and psychical symptoms in postmenopausal women.Acta Obstet Gynecol Scand.1984636556616440406
   PubMed Web of Science ®Google Scholar
• SoaresCN.AlmeidaOP.JoffeH.CohenLS.Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a doubleblind, randomized, placebo-controlled trial.Arch Gen Psychiatry.20015852953411386980
   PubMed Web of Science ®Google Scholar
• SchmidtPJ.NiemanL.DanaceauMA.et al.Estrogen replacement in perimenopause-related depression: a preliminary report.Am J Obstet Gynecol.200018341442010942479
   PubMed Web of Science ®Google Scholar
• BlümelJE.Castelo-BrancoC.BinfaL.AparicioR.MamaniL.A scheme of combined oral contraceptives for women more than 40 years old.Menopause.2001828628911449087
   PubMed Web of Science ®Google Scholar
• KornsteinSG.SchatzbergAF.ThaseME.et al.Gender differences in treatment response to sertraline versus imipramine in chronic depression.Am J Psychiatry.20001571445145210964861
   PubMed Web of Science ®Google Scholar
• MartenyiF.DossenbachM.MrazK.MetcalfeS.Gender differences in the efficacy of fluoxetine and maprotiline in depressed patients: a doubleblind trial of antidepressants with serotonergic or norepinephrinergic reuptake inhibition profile.Eur Neuropsychopharmacol.20011122723211418283
   PubMed Web of Science ®Google Scholar
• SchneiderLS.SmallGW.HamiltonSH.BystritakyA.NemeroffCB.MeyersBS.Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial.Am J Geriatr Psychiatry.19975971069106373
   PubMed Web of Science ®Google Scholar
• SchneiderLS.SmallGW.ClaryCM.Estrogen replacement therapy and antidepressant response to sertraline in older depressed women.Am J Geriatr Psychiatry.2001939339911739065
   PubMed Web of Science ®Google Scholar
• AmsterdamJ.Garcia-EspanaF.FawcettJ.et al.Fluoxetine efficacy in menopausal women with and without estrogen replacement.J Affect Disord.199955111710512601
   PubMed Web of Science ®Google Scholar
• SperoffL.GlassRH.KaseNG.Clinical Gynecologic Endocrinology and Infertility 6th ed. Baltimore, Md: Lippincott Williams & Wilkins;1999
   Google Scholar
• KaunitzAM.Oral contraceptive use in perimenopause.Am J Obstet Gynecol.2001185532537
   Web of Science ®Google Scholar
• RannevikG.JeppssonS.JohnellO.BjerreB.Laurell-BorulfY.SvanbergL.A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density.Maturitas.1995211031137752947
   PubMed Web of Science ®Google Scholar
• BurgerHG.DudleyEC.HopperJL.et al.Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women.J Clin Endocrinol Metab.1999844025403010566644
   PubMed Web of Science ®Google Scholar
• O'HaraMW.NeunaberDJ.ZekowskiEM.Prospective study of postpartum depression: prevalence, course, and predictive factors.J Abnorm Psychol.1984931581716725749
   PubMed Web of Science ®Google Scholar
• GeorgiopoulosAM.BryanTL.WollanP.YawnBP.Routine screening for postpartum depression.J Fam Pract.20015011712211219558
   PubMed Web of Science ®Google Scholar
• KendellRE.ChalmersJC.PlatzC.Epidemiology of puerperal psychoses.Br J Psychiatry.19871506626733651704
   PubMed Web of Science ®Google Scholar
• PopVJM.EssedGGM.DeGeusCA.van SonMM.KomproeIH.Prevalence of post partum depression - or is it post-puerperium depression?Acta Obstet Gynecol Scand.1993723543588392265
   PubMed Web of Science ®Google Scholar
• EvansJ.HeronJ.FrancombH.OkeS.GoldingJ.Cohort study of depressed mood during pregnancy and after childbirth.BMJ.200132325726011485953
   PubMed Web of Science ®Google Scholar
• JosefssonA.BergG.NordinC.SydsjoG.Prevalence of depressive symptoms in late pregnancy and postpartum.Acta Obstet Gynecol Scand.20018025125511207491
   PubMed Web of Science ®Google Scholar
• AffonsoDD.MayberryLJ.LovettS.et al.Pregnancy and postpartum depressive symptoms.J Women's Health.19932157164
   Google Scholar
• PearlsteinTB.FrankE.Rivera-TovarA.ThoftJS.JacobsE.MieczkowskiTA.Prevalence of axis I and axis II disorders in women with late luteal phase dysphoric disorder.J Affect Disord.1990201291342148327
   PubMed Web of Science ®Google Scholar
• ChuongCJ.BurgosDM.Medical history in women with premenstrual syndrome.J Psychosom Obstet Gynaecol.19951621277787954
   PubMed Web of Science ®Google Scholar
• JermainDM.Psychopharmacologic approach to postpartum depression.J Women's Health.199214752
   Google Scholar
• ApplebyL.WarnerR.WhittonA.et al.A controlled study of fluoxetine and cognitive-behavioral counseling in the treatment of postnatal depression.BMJ.19973149329369099116
   PubMed Web of Science ®Google Scholar
• StoweZN.CasarellaJ.LandryJ.et al.Sertraline in the treatment of women with postpartum major depression.Depression.199534955
   Google Scholar
• CohenLS.VigueraAC.BouffardSM.NonacsRM.MorabitoC.Collins AblonJS.Venlafaxine in the treatment of postpartum depression.J Clin Psychiatry.20016259229611561929
   PubMed Web of Science ®Google Scholar
• SuriR.BurtVK.AltshulerL.Zuckerbrow-MillerJ.FairbanksL.Fluvoxamine for the treatment of postpartum depression.Am J Psychiatry.20011581739174011579021
   PubMed Web of Science ®Google Scholar
• HendrickV.AltshulerL.StrouseT.GrosserS.Postpartum and nonpostpartum depression: differences in presentation and response to pharmacologic treatment.Depress Anxiety.200011667210812531
   PubMed Web of Science ®Google Scholar
• NewportDJ.WilcoxMM.StoweZN.Antidepressants during pregnancy and lactation: defining exposure and treatment issues.Semin Perinatol.20012517719011453615
   PubMed Web of Science ®Google Scholar
• HendrickV.StoweZN.AltshulerLL.et al.Fluoxetine and norfluoxetine concentrations in nursing infants and breast milk.Biol Psychiatry.20015077578211720696
   PubMed Web of Science ®Google Scholar
• HendrickV.StoweZN.AltshulerLL.et al.Paroxetine use during breastfeeding.J Clin Psychopharmacol.20002058758911001251
   PubMed Web of Science ®Google Scholar
• WisnerKL.PerelJM.FindlingRL.Antidepressant treatment during breast-feeding.Am J Psychiatry.1996153113211378780414
   PubMed Web of Science ®Google Scholar
• WisnerKL.PerelJM.BlumerJ.Serum sertraline and N-desmethylsertraline levels in breast-feeding mother-infant pairs.Am J Psychiatry.19981556906929585724
   PubMed Web of Science ®Google Scholar
• StoweZN.CohenLS.HostetterA.et al.Paroxetine in human breast milk and nursing infants.Am J Psychiatry.200015718518910671385
   PubMed Web of Science ®Google Scholar
• PiontekCM.WisnerKL.PerelJM.PeindlKS.Serum fluvoxamine levels in breastfed infants.J Clin Psychiatry.20016211111311247095
   PubMed Web of Science ®Google Scholar
• WisnerKL.PerelJM.PeindlKS.HanusaBH.FindlingRL.RapportD.Prevention of recurrent postpartum depression: a randomized clinical trial.J Clin Psychiatry.200162828611247106
   PubMed Web of Science ®Google Scholar
• AhokasA.KaukorantaJutta.WahlbeckK.AitoM.Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17β-estradiol: a preliminary study.J Clin Psychiatry.20016233233611411813
   PubMed Web of Science ®Google Scholar
• AhokasA.AitoM.RimónR.Positive treatment effect of estradiol in postpartum psychosis: a pilot study.J Clin Psychiatry.20006116616910817099
   PubMed Web of Science ®Google Scholar
• GregoireAJ.KumarR.EverittB.et al.Transdermal oestrogen for treatment of severe postnatal depression.Lancet.19963479309338598756
   PubMed Web of Science ®Google Scholar
• SichelDA.CohenLS.RobertsonLM.et al.Prophylactic estrogen in recurrent postpartum affective disorder.Biol Psychiatry.1995388148188750040
   PubMed Web of Science ®Google Scholar
• EppersonCN.WisnerKL.YamamotoB.Gonadal steroids in the treatment of mood disorders.Psychosom Med.19996167669710511016
   PubMed Web of Science ®Google Scholar
• GrangerAC.UnderwoodMR.Review of the role of progesterone in the management of postnatal mood disorders.J Psychosom Obstet Gynaecol.200122495511317610
   PubMed Web of Science ®Google Scholar
• LawrieTA.HofmeyrGJ.De JagerM.BerkM.PaikerJ.ViljoenE.A double-blind randomised placebo-controlled trial of postnatal norethisterone enanthate: the effect on postnatal depression and serum hormones.Br J Obstet Gynaecol.1998105108210909800931
   PubMedGoogle Scholar
• O'HaraMW.StuartS.GormanLL.WenzelA.Efficacy of interpersonal psychotherapy for postpartum depression.Arch Gen Psychiatry.2000571039104511074869
   PubMed Web of Science ®Google Scholar
• EvinsGG.TheofrastousJP.GalvinSL.Postpartum depression: a comparison of screening and routine clinical evaluation.Am J Obstet Gynecol.20001821080108210819833
   PubMed Web of Science ®Google Scholar
• BeckCT.The effects of postpartum depression on child development: a meta-analysis.Arch Psychiatr Nurs.19981212209489170
   PubMed Web of Science ®Google Scholar
• CoxJL.HoldenJM.SagovskyR.Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale.Br J Psychiatry.19871507827863651732
   PubMed Web of Science ®Google Scholar